CVS Health (CVS) Insider Trading & Ownership $63.87 +0.29 (+0.46%) Closing price 06/9/2025 03:59 PM EasternExtended Trading$63.98 +0.11 (+0.16%) As of 07:09 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CVS Health (NYSE:CVS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.22%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$2.10MNumber OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$498.49K Get CVS Insider Trade Alerts Want to know when executives and insiders are buying or selling CVS Health stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CVS Insider Buying and Selling by Quarter CVS Health Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/5/2025Guy P SansoneDirectorBuy1,570$63.70$100,009.00 5/15/2025Robert Bresnahan, Jr.U.S. Congress Member (R-PA)Sell$60.42$1,001 - $15,0004/10/2025Michael T. McCaulU.S. Congress Member (R-TX)Sell$68.86$100,001 - $250,0004/1/2025Julie JohnsonU.S. Congress Member (D-TX)Sell$67.88$1,001 - $15,0003/5/2025James David ClarkSVPSell7,513$66.35$498,487.55 2/25/2025Robert Bresnahan, Jr.U.S. Congress Member (R-PA)Buy$63.65$1,001 - $15,0002/18/2025Michael F MahoneyDirectorBuy30,000$66.70$2,001,000.00 (Data available from 1/1/2013 forward) CVS Insider Trading Activity - Frequently Asked Questions Who is on CVS Health's Insider Roster? The list of insiders at CVS Health includes Alan Lotvin, Edward J Ludwig, Guy P Sansone, James David Clark, Karen S Lynch, Michael F Mahoney, Prem S Shah, and Thomas M Moriarty. Learn more on insiders at CVS. What percentage of CVS Health stock is owned by insiders? 1.22% of CVS Health stock is owned by insiders. Learn more on CVS's insider holdings. Which CVS Health insiders have been buying company stock? The following insiders have purchased CVS shares in the last 24 months: Edward J Ludwig ($194,820.00), Guy P Sansone ($100,009.00), and Michael F Mahoney ($2,001,000.00). How much insider buying is happening at CVS Health? Insiders have purchased a total of 34,570 CVS shares in the last 24 months for a total of $2,295,829.00 bought. Which CVS Health insiders have been selling company stock? The following insiders have sold CVS shares in the last 24 months: James David Clark ($2,428,351.83), and Prem S Shah ($2,267,947.35). How much insider selling is happening at CVS Health? Insiders have sold a total of 62,745 CVS Health shares in the last 24 months for a total of $4,696,299.18 sold. Which members of congress are trading CVS Health? Robert Bresnahan, Jr. (R-PA) and Gilbert Ray Cisneros, Jr. (D-CA) have bought shares of CVS Health in the last year totaling $16,000. Robert Bresnahan, Jr. (R-PA), Michael T. McCaul (R-TX), Julie Johnson (D-TX), J. French Hill (R-AR), Thomas R. Suozzi (D-NY), Tommy Tuberville (R-AL), and Earl Blumenauer (D-OR) have sold shares totaling $255,500. CVS Health Key ExecutivesMs. Karen Sue Lynch (Age 61)President, CEO & Director Compensation: $5.12MMr. Thomas Francis Cowhey (Age 52)Executive VP & CFO Compensation: $1.83MMr. Tilak Mandadi (Age 59)Executive VP of Ventures and Chief Digital, Data, Analytics & Technology Officer Compensation: $2.38MMr. Samrat S. Khichi Esq. (Age 57)Executive VP, Chief Policy Officer & General Counsel Compensation: $3.39MMr. Prem S. Shah Pharm.D (Age 44)Executive VP, Chief Pharmacy Officer and President of Pharmacy & Consumer Wellness Compensation: $2.58MMr. Vijay PatelSenior Director of Business Development & CVS Health and Partner & Co-FounderMr. James David Clark (Age 59)Senior VP, Controller & Chief Accounting Officer 1 recent tradesMr. David A. FalkowskiExecutive VP & Chief Compliance OfficerMs. Heidi B. Capozzi (Age 54)Executive VP & Chief People Officer Mr. J. David Joyner CEBS (Age 59)Executive Vice President & President of CVS Caremark More Insider Trading Tools from MarketBeat Related Companies Walgreens Boots Alliance Insider Buying Guardian Pharmacy Services Insider Buying PetMed Express Insider Buying UnitedHealth Group Insider Buying Novartis Insider Buying Abbott Laboratories Insider Buying AstraZeneca Insider Buying Intuitive Surgical Insider Buying Merck & Co., Inc. Insider Buying Amgen Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Tightly-Held Growth Stocks Set Up for Short Squeezes3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders BoughtMeta's Institutional & Insider Data Fuels Bulls Despite DisparityTurbulence for Joby Shares: What's Behind the Recent Dip? This page (NYSE:CVS) was last updated on 6/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy 2026 will be a disaster for many Americans2025 Market Crash The first-quarter stock crash left investors wondering what lies ahead. Today 50-year Wal...Chaikin Analytics | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredElon’s “Secret Mission”Tesla, SpaceX and Starlink made billions for investors... But a meeting Elon had on March 21st, 2025, could...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVS Health Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share CVS Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.